HDAC9 and lymphoma: To determine the ability of the tumors to be pharmacologically induced into lytic replication, mice were treated with a 4 day course of Vorinostat (SAHA) a FDA approved HDAC inhibitor currently being tested in viral and non-viral lymphomas.